Approval in severe-to-profound and profound OTOF -related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of ...
Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.
Oligo Security moves beyond CVE prioritization with real-time application-layer exploit blocking - SiliconANGLE ...
CEO William Krueger began by thanking the team for delivering a record fourth quarter EPS, emphasizing the portfolio's versatility and resilience. He noted, "The fall harvest produced ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. When Kulindu Vithanachchi’s phone lit up with an update from the National Science ...
Alibaba Tongyi Lab research team released ‘Zvec’, an open source, in-process vector database that targets edge and on-device retrieval workloads. It is positioned as ‘the SQLite of vector databases’ ...
After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the FDA. In rejecting RGX-121, the FDA raised concerns about its clinical ...
ABSTRACT: In predator-prey population model, the density capacity restricts the growth rate of prey population. Prey species is assumed with θ logistic growth rate, which is θ exponent dependent. The ...
Mortgage purchase applications reached a three-year high as improved spreads kept rates near 6% for 18 weeks. Inventory growth and slower price gains also supported stronger buyer demand in late 2025.
Qdrant, the open-source vector search engine used by enterprises and AI-native teams, announced Tiered Multitenancy—as part of the v1.16 release—a new capability that helps organizations isolate heavy ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results